Literature DB >> 34606337

Efficacy of Nanoencapsulated Daptomycin in an Experimental Methicillin-Resistant Staphylococcus aureus Bone and Joint Infection Model.

Cedric Jacqueline1,2, Jocelyne Caillon1,2, Olivier Meyer3, Eric Dailly4,5, Carl Simonsson3, Vincent Lenaerts6, Karim Asehnoune1,7, Amokrane Reghal2, Gilles Potel1,2.   

Abstract

Staphylococcus aureus bone infections remain a therapeutic challenge, leading to long and expensive hospitalizations. Systemic antibiotic treatments are inconsistently effective, due to insufficient penetration into the infectious site. In an osteomyelitis model, the single local administration of nanoparticle-encapsulated daptomycin allows sterilization of the infectious sites after 4 and 14 days of treatment, while daily systemic daptomycin treatment for 4 days was not effective. These results demonstrate the great potential of this local antibiotic treatment.

Entities:  

Keywords:  MRSA; daptomycin; lipopeptides; local delivery; nanoparticles; osteomyelitis

Mesh:

Substances:

Year:  2021        PMID: 34606337      PMCID: PMC8597761          DOI: 10.1128/AAC.00768-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Non-traditional Antibacterial Therapeutic Options and Challenges.

Authors:  Ursula Theuretzbacher; Laura J V Piddock
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

2.  Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Douglas R Osmon; Elie F Berbari; Anthony R Berendt; Daniel Lew; Werner Zimmerli; James M Steckelberg; Nalini Rao; Arlen Hanssen; Walter R Wilson
Journal:  Clin Infect Dis       Date:  2012-12-06       Impact factor: 9.079

3.  Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection.

Authors:  Yanhong Li; Tingting Su; Yan Zhang; Xingliang Huang; Jing Li; Chong Li
Journal:  Drug Deliv       Date:  2014-01-29       Impact factor: 6.419

4.  A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.

Authors:  Willemijn Boot; Tanja Schmid; Matteo D'Este; Olivier Guillaume; Andrew Foster; Laurent Decosterd; Robert G Richards; David Eglin; Stephan Zeiter; Thomas F Moriarty
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.

Authors:  M Lefebvre; C Jacqueline; G Amador; V Le Mabecque; A Miegeville; G Potel; J Caillon; N Asseray
Journal:  Int J Antimicrob Agents       Date:  2010-09-18       Impact factor: 5.283

6.  Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Authors:  Cédric Jacqueline; Gilles Amador; Eric Batard; Virginie Le Mabecque; Anne-Françoise Miègeville; Donald Biek; Jocelyne Caillon; Gilles Potel
Journal:  J Antimicrob Chemother       Date:  2011-01-31       Impact factor: 5.790

Review 7.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.

Authors:  A Saleh Mghir; A C Crémieux; R Bleton; F Ismael; M Manteau; S Dautrey; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Prosthesis joint infections: contributions of experimental models to understanding the limitations of antibiotic efficacy and optimization of medical treatment.

Authors:  Anne-Claude Crémieux
Journal:  Bull Acad Natl Med       Date:  2016-02       Impact factor: 0.144

10.  Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections.

Authors:  Ester J Kwon; Matthew Skalak; Alessandro Bertucci; Gary Braun; Francesco Ricci; Erkki Ruoslahti; Michael J Sailor; Sangeeta N Bhatia
Journal:  Adv Mater       Date:  2017-07-12       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.